−520 KRW
−21.11 B KRW
3.13 B KRW
19.42 M
About EYEGENE,INC
Sector
Industry
CEO
Won-Il Yoo
Website
Headquarters
Uiwang-si
Founded
2000
ISIN
KR7185490000
FIGI
BBG005MYY5W5
Eyegene, Inc. engages in the research and development of pharmaceutical products. Its products include curing technologies and vaccines for diabetic retinopathy, decubitus ulcer, cervical cancer, and adjuvant immunotherapy. The company was founded on June 23, 2000 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 185490 is 2,675 KRW — it has decreased by −2.01% in the past 24 hours. Watch EYEGENE,INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange EYEGENE,INC stocks are traded under the ticker 185490.
185490 stock has fallen by −4.46% compared to the previous week, the month change is a −6.96% fall, over the last year EYEGENE,INC has showed a −31.59% decrease.
185490 reached its all-time high on Sep 1, 2021 with the price of 60,200 KRW, and its all-time low was 2,430 KRW and was reached on Jun 24, 2024. View more price dynamics on 185490 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
185490 stock is 8.74% volatile and has beta coefficient of 0.70. Track EYEGENE,INC stock price on the chart and check out the list of the most volatile stocks — is EYEGENE,INC there?
Today EYEGENE,INC has the market capitalization of 72.30 B, it has decreased by −3.01% over the last week.
Yes, you can track EYEGENE,INC financials in yearly and quarterly reports right on TradingView.
185490 net income for the last quarter is −3.30 B KRW, while the quarter before that showed −2.96 B KRW of net income which accounts for −11.49% change. Track more EYEGENE,INC financial stats to get the full picture.
No, 185490 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 88.00 employees. See our rating of the largest employees — is EYEGENE,INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EYEGENE,INC EBITDA is −12.26 B KRW, and current EBITDA margin is −798.26%. See more stats in EYEGENE,INC financial statements.
Like other stocks, 185490 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EYEGENE,INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EYEGENE,INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EYEGENE,INC stock shows the sell signal. See more of EYEGENE,INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.